Form 4: Zivo Bioscience Director Alison Cornell Reports Share Acquisition and Disposal
SEC Form 4
Director Alison Cornell reports acquiring 37,688 shares of Zivo Bioscience and disposing of 83,854 shares on May 31, 2024.
Summary
- On May 31, 2024, Alison Cornell, a director of Zivo Bioscience, Inc., reported a transaction involving the company's common stock.
- Cornell acquired 37,688 shares at $0.
- Simultaneously, Cornell disposed of 83,854 shares.
- Following these transactions, Cornell beneficially owns 83,854 shares of Zivo Bioscience.
Sentiment
Score: 5
Explanation: This is a neutral report of insider trading activity, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like directors, who trade in their company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- Shareholders may be interested in this information as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of the reported transaction (acquisition and disposal of shares). |
| 06/04/2024 | Date of signature on the Form 4 filing. |
Keywords
Zivo Bioscience, Director, Share Acquisition, Share Disposal, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.